E-Clinical Trial Solutions - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509247981

Publication Date:

September 23, 2024

Pages:

160

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for E-Clinical Trial Solutions was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for E-Clinical Trial Solutions was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for E-Clinical Trial Solutions was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for E-Clinical Trial Solutions was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of E-Clinical Trial Solutions include BioClinica, Parexel, Perceptive Informatics, EClinical Solutions, Ecrfplus, Clincase, Merge, Oracle and Medidata Solutions, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for E-Clinical Trial Solutions, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of E-Clinical Trial Solutions by region & country, by Type, and by Application.
The E-Clinical Trial Solutions market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding E-Clinical Trial Solutions.
麻豆原创 Segmentation
By Company
BioClinica
Parexel
Perceptive Informatics
EClinical Solutions
Ecrfplus
Clincase
Merge
Oracle
Medidata Solutions
Clinpal
NTT DATA
Datatrak
Omnicomm
MedNet Solutions
Prelude Dynamics
Nextrials
DSG
EClinForce
Almac
ArisGlobal
DigiGenomics
Segment by Type:
Clinical Data Management System (CDMS) Solutions
Clinical Trial Management System (CTMS) Solutions
Electronic Clinical Outcomes Assessment (eCOA) Solutions
Randomization and Trial Supply Management (RTSM) Solutions
Other
Segment by Application
Medical Laboratory
Hospital
Pharmaceutical Company
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of E-Clinical Trial Solutions manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of E-Clinical Trial Solutions in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of E-Clinical Trial Solutions in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 E-Clinical Trial Solutions Product Introduction
1.2 Global E-Clinical Trial Solutions 麻豆原创 Size Forecast
1.3 E-Clinical Trial Solutions 麻豆原创 Trends & Drivers
1.3.1 E-Clinical Trial Solutions Industry Trends
1.3.2 E-Clinical Trial Solutions 麻豆原创 Drivers & Opportunity
1.3.3 E-Clinical Trial Solutions 麻豆原创 Challenges
1.3.4 E-Clinical Trial Solutions 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global E-Clinical Trial Solutions Players Revenue Ranking (2023)
2.2 Global E-Clinical Trial Solutions Revenue by Company (2019-2024)
2.3 Key Companies E-Clinical Trial Solutions Manufacturing Base Distribution and Headquarters
2.4 Key Companies E-Clinical Trial Solutions Product Offered
2.5 Key Companies Time to Begin Mass Production of E-Clinical Trial Solutions
2.6 E-Clinical Trial Solutions 麻豆原创 Competitive Analysis
2.6.1 E-Clinical Trial Solutions 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by E-Clinical Trial Solutions Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in E-Clinical Trial Solutions as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Clinical Data Management System (CDMS) Solutions
3.1.2 Clinical Trial Management System (CTMS) Solutions
3.1.3 Electronic Clinical Outcomes Assessment (eCOA) Solutions
3.1.4 Randomization and Trial Supply Management (RTSM) Solutions
3.1.5 Other
3.2 Global E-Clinical Trial Solutions Sales Value by Type
3.2.1 Global E-Clinical Trial Solutions Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global E-Clinical Trial Solutions Sales Value, by Type (2019-2030)
3.2.3 Global E-Clinical Trial Solutions Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Medical Laboratory
4.1.2 Hospital
4.1.3 Pharmaceutical Company
4.1.4 Other
4.2 Global E-Clinical Trial Solutions Sales Value by Application
4.2.1 Global E-Clinical Trial Solutions Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global E-Clinical Trial Solutions Sales Value, by Application (2019-2030)
4.2.3 Global E-Clinical Trial Solutions Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global E-Clinical Trial Solutions Sales Value by Region
5.1.1 Global E-Clinical Trial Solutions Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global E-Clinical Trial Solutions Sales Value by Region (2019-2024)
5.1.3 Global E-Clinical Trial Solutions Sales Value by Region (2025-2030)
5.1.4 Global E-Clinical Trial Solutions Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America E-Clinical Trial Solutions Sales Value, 2019-2030
5.2.2 North America E-Clinical Trial Solutions Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe E-Clinical Trial Solutions Sales Value, 2019-2030
5.3.2 Europe E-Clinical Trial Solutions Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific E-Clinical Trial Solutions Sales Value, 2019-2030
5.4.2 Asia Pacific E-Clinical Trial Solutions Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America E-Clinical Trial Solutions Sales Value, 2019-2030
5.5.2 South America E-Clinical Trial Solutions Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa E-Clinical Trial Solutions Sales Value, 2019-2030
5.6.2 Middle East & Africa E-Clinical Trial Solutions Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions E-Clinical Trial Solutions Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions E-Clinical Trial Solutions Sales Value
6.3 United States
6.3.1 United States E-Clinical Trial Solutions Sales Value, 2019-2030
6.3.2 United States E-Clinical Trial Solutions Sales Value by Type (%), 2023 VS 2030
6.3.3 United States E-Clinical Trial Solutions Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe E-Clinical Trial Solutions Sales Value, 2019-2030
6.4.2 Europe E-Clinical Trial Solutions Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe E-Clinical Trial Solutions Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China E-Clinical Trial Solutions Sales Value, 2019-2030
6.5.2 China E-Clinical Trial Solutions Sales Value by Type (%), 2023 VS 2030
6.5.3 China E-Clinical Trial Solutions Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan E-Clinical Trial Solutions Sales Value, 2019-2030
6.6.2 Japan E-Clinical Trial Solutions Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan E-Clinical Trial Solutions Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea E-Clinical Trial Solutions Sales Value, 2019-2030
6.7.2 South Korea E-Clinical Trial Solutions Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea E-Clinical Trial Solutions Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia E-Clinical Trial Solutions Sales Value, 2019-2030
6.8.2 Southeast Asia E-Clinical Trial Solutions Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia E-Clinical Trial Solutions Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India E-Clinical Trial Solutions Sales Value, 2019-2030
6.9.2 India E-Clinical Trial Solutions Sales Value by Type (%), 2023 VS 2030
6.9.3 India E-Clinical Trial Solutions Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 BioClinica
7.1.1 BioClinica Profile
7.1.2 BioClinica Main Business
7.1.3 BioClinica E-Clinical Trial Solutions Products, Services and Solutions
7.1.4 BioClinica E-Clinical Trial Solutions Revenue (US$ Million) & (2019-2024)
7.1.5 BioClinica Recent Developments
7.2 Parexel
7.2.1 Parexel Profile
7.2.2 Parexel Main Business
7.2.3 Parexel E-Clinical Trial Solutions Products, Services and Solutions
7.2.4 Parexel E-Clinical Trial Solutions Revenue (US$ Million) & (2019-2024)
7.2.5 Parexel Recent Developments
7.3 Perceptive Informatics
7.3.1 Perceptive Informatics Profile
7.3.2 Perceptive Informatics Main Business
7.3.3 Perceptive Informatics E-Clinical Trial Solutions Products, Services and Solutions
7.3.4 Perceptive Informatics E-Clinical Trial Solutions Revenue (US$ Million) & (2019-2024)
7.3.5 EClinical Solutions Recent Developments
7.4 EClinical Solutions
7.4.1 EClinical Solutions Profile
7.4.2 EClinical Solutions Main Business
7.4.3 EClinical Solutions E-Clinical Trial Solutions Products, Services and Solutions
7.4.4 EClinical Solutions E-Clinical Trial Solutions Revenue (US$ Million) & (2019-2024)
7.4.5 EClinical Solutions Recent Developments
7.5 Ecrfplus
7.5.1 Ecrfplus Profile
7.5.2 Ecrfplus Main Business
7.5.3 Ecrfplus E-Clinical Trial Solutions Products, Services and Solutions
7.5.4 Ecrfplus E-Clinical Trial Solutions Revenue (US$ Million) & (2019-2024)
7.5.5 Ecrfplus Recent Developments
7.6 Clincase
7.6.1 Clincase Profile
7.6.2 Clincase Main Business
7.6.3 Clincase E-Clinical Trial Solutions Products, Services and Solutions
7.6.4 Clincase E-Clinical Trial Solutions Revenue (US$ Million) & (2019-2024)
7.6.5 Clincase Recent Developments
7.7 Merge
7.7.1 Merge Profile
7.7.2 Merge Main Business
7.7.3 Merge E-Clinical Trial Solutions Products, Services and Solutions
7.7.4 Merge E-Clinical Trial Solutions Revenue (US$ Million) & (2019-2024)
7.7.5 Merge Recent Developments
7.8 Oracle
7.8.1 Oracle Profile
7.8.2 Oracle Main Business
7.8.3 Oracle E-Clinical Trial Solutions Products, Services and Solutions
7.8.4 Oracle E-Clinical Trial Solutions Revenue (US$ Million) & (2019-2024)
7.8.5 Oracle Recent Developments
7.9 Medidata Solutions
7.9.1 Medidata Solutions Profile
7.9.2 Medidata Solutions Main Business
7.9.3 Medidata Solutions E-Clinical Trial Solutions Products, Services and Solutions
7.9.4 Medidata Solutions E-Clinical Trial Solutions Revenue (US$ Million) & (2019-2024)
7.9.5 Medidata Solutions Recent Developments
7.10 Clinpal
7.10.1 Clinpal Profile
7.10.2 Clinpal Main Business
7.10.3 Clinpal E-Clinical Trial Solutions Products, Services and Solutions
7.10.4 Clinpal E-Clinical Trial Solutions Revenue (US$ Million) & (2019-2024)
7.10.5 Clinpal Recent Developments
7.11 NTT DATA
7.11.1 NTT DATA Profile
7.11.2 NTT DATA Main Business
7.11.3 NTT DATA E-Clinical Trial Solutions Products, Services and Solutions
7.11.4 NTT DATA E-Clinical Trial Solutions Revenue (US$ Million) & (2019-2024)
7.11.5 NTT DATA Recent Developments
7.12 Datatrak
7.12.1 Datatrak Profile
7.12.2 Datatrak Main Business
7.12.3 Datatrak E-Clinical Trial Solutions Products, Services and Solutions
7.12.4 Datatrak E-Clinical Trial Solutions Revenue (US$ Million) & (2019-2024)
7.12.5 Datatrak Recent Developments
7.13 Omnicomm
7.13.1 Omnicomm Profile
7.13.2 Omnicomm Main Business
7.13.3 Omnicomm E-Clinical Trial Solutions Products, Services and Solutions
7.13.4 Omnicomm E-Clinical Trial Solutions Revenue (US$ Million) & (2019-2024)
7.13.5 Omnicomm Recent Developments
7.14 MedNet Solutions
7.14.1 MedNet Solutions Profile
7.14.2 MedNet Solutions Main Business
7.14.3 MedNet Solutions E-Clinical Trial Solutions Products, Services and Solutions
7.14.4 MedNet Solutions E-Clinical Trial Solutions Revenue (US$ Million) & (2019-2024)
7.14.5 MedNet Solutions Recent Developments
7.15 Prelude Dynamics
7.15.1 Prelude Dynamics Profile
7.15.2 Prelude Dynamics Main Business
7.15.3 Prelude Dynamics E-Clinical Trial Solutions Products, Services and Solutions
7.15.4 Prelude Dynamics E-Clinical Trial Solutions Revenue (US$ Million) & (2019-2024)
7.15.5 Prelude Dynamics Recent Developments
7.16 Nextrials
7.16.1 Nextrials Profile
7.16.2 Nextrials Main Business
7.16.3 Nextrials E-Clinical Trial Solutions Products, Services and Solutions
7.16.4 Nextrials E-Clinical Trial Solutions Revenue (US$ Million) & (2019-2024)
7.16.5 Nextrials Recent Developments
7.17 DSG
7.17.1 DSG Profile
7.17.2 DSG Main Business
7.17.3 DSG E-Clinical Trial Solutions Products, Services and Solutions
7.17.4 DSG E-Clinical Trial Solutions Revenue (US$ Million) & (2019-2024)
7.17.5 DSG Recent Developments
7.18 EClinForce
7.18.1 EClinForce Profile
7.18.2 EClinForce Main Business
7.18.3 EClinForce E-Clinical Trial Solutions Products, Services and Solutions
7.18.4 EClinForce E-Clinical Trial Solutions Revenue (US$ Million) & (2019-2024)
7.18.5 EClinForce Recent Developments
7.19 Almac
7.19.1 Almac Profile
7.19.2 Almac Main Business
7.19.3 Almac E-Clinical Trial Solutions Products, Services and Solutions
7.19.4 Almac E-Clinical Trial Solutions Revenue (US$ Million) & (2019-2024)
7.19.5 Almac Recent Developments
7.20 ArisGlobal
7.20.1 ArisGlobal Profile
7.20.2 ArisGlobal Main Business
7.20.3 ArisGlobal E-Clinical Trial Solutions Products, Services and Solutions
7.20.4 ArisGlobal E-Clinical Trial Solutions Revenue (US$ Million) & (2019-2024)
7.20.5 ArisGlobal Recent Developments
7.21 DigiGenomics
7.21.1 DigiGenomics Profile
7.21.2 DigiGenomics Main Business
7.21.3 DigiGenomics E-Clinical Trial Solutions Products, Services and Solutions
7.21.4 DigiGenomics E-Clinical Trial Solutions Revenue (US$ Million) & (2019-2024)
7.21.5 DigiGenomics Recent Developments
8 Industry Chain Analysis
8.1 E-Clinical Trial Solutions Industrial Chain
8.2 E-Clinical Trial Solutions Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 E-Clinical Trial Solutions Sales Model
8.5.2 Sales Channel
8.5.3 E-Clinical Trial Solutions Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

BioClinica
Parexel
Perceptive Informatics
EClinical Solutions
Ecrfplus
Clincase
Merge
Oracle
Medidata Solutions
Clinpal
NTT DATA
Datatrak
Omnicomm
MedNet Solutions
Prelude Dynamics
Nextrials
DSG
EClinForce
Almac
ArisGlobal
DigiGenomics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.